» Articles » PMID: 32529023

Prognostic Assessment of Relative Apical Sparing Pattern of Longitudinal Strain for Severe Aortic Valve Stenosis

Overview
Date 2020 Jun 13
PMID 32529023
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Backgrounds: The relative apical sparing pattern (RASP) of left ventricular (LV) longitudinal strain (LS) is frequently associated with cardiac amyloidosis. Elderly patients with aortic valve stenosis (AS) complicated by transthyretin amyloid cardiomyopathy have poor prognosis. Furthermore, deteriorated basal LS in AS patients has been reported to be associated with adverse outcome. We investigated the association between RASP and outcomes in patients with severe AS.

Methods: We retrospectively studied 156 consecutive patients with severe AS and preserved LV ejection fraction. RASP was assessed by both of semi-quantitative (sRASP) and quantitative (qRASP) methods. sRASP was defined as a deterioration of LS (≥-10%) in ≥ 5 (of 6) basal segments, relative to preserved LS (<-15%) in at least 1 apical segment. qRASP was calculated using the following formula: average apical LS/(average basal LS + average mid-ventricle LS); qRASP ≥ 1 was defined as positive. Patients were followed up to determine outcomes, which included sudden cardiac death or unexpected admission due to heart failure, over a median of 1.9 years.

Results: sRASP and qRASP were assessed in all patients, but 24 and 42 patients fulfilled the criteria for sRASP and qRASP, respectively. Both assessments were significantly associated with outcomes (n = 44; 28%). Furthermore, sRASP was significantly associated with outcome after adjusting for EuroSCORE, NYHA ≥ II, or global longitudinal strain. A model based on these covariates for predicting outcomes significantly improved by adding sRASP.

Conclusion: RASP is observed in some patients with severe AS and provides additive prognostic information over conventional parameters.

Citing Articles

Red Flags, Prognostic Impact, and Management of Patients With Cardiac Amyloidosis and Aortic Valve Stenosis: A Systematic Review and Meta-Analysis.

Myasoedova V, Conte M, Valerio V, Moschetta D, Massaiu I, Petraglia L Front Med (Lausanne). 2022; 9:858281.

PMID: 35355593 PMC: 8959832. DOI: 10.3389/fmed.2022.858281.


Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.

Shimoni S, Zikri M, Haberman D, Livschitz S, Tshori S, Fabricant Y ESC Heart Fail. 2021; 8(6):4549-4561.

PMID: 34704399 PMC: 8712785. DOI: 10.1002/ehf2.13667.


Cardiac amyloidosis screening using a relative apical sparing pattern in patients with left ventricular hypertrophy.

Nakao Y, Saito M, Inoue K, Higaki R, Yokomoto Y, Ogimoto A Cardiovasc Ultrasound. 2021; 19(1):30.

PMID: 34425846 PMC: 8383373. DOI: 10.1186/s12947-021-00258-x.


Restricted left atrial dilatation can visually differentiate cardiac amyloidosis from hypertrophic cardiomyopathy.

Higashi H, Inoue K, Inaba S, Nakao Y, Kinoshita M, Miyazaki S ESC Heart Fail. 2021; 8(4):3198-3205.

PMID: 34042317 PMC: 8318458. DOI: 10.1002/ehf2.13442.

References
1.
Kusunose K, Goodman A, Parikh R, Barr T, Agarwal S, Popovic Z . Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction. Circ Cardiovasc Imaging. 2014; 7(6):938-45. DOI: 10.1161/CIRCIMAGING.114.002041. View

2.
Gillmore J, Maurer M, Falk R, Merlini G, Damy T, Dispenzieri A . Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016; 133(24):2404-12. DOI: 10.1161/CIRCULATIONAHA.116.021612. View

3.
Treibel T, Fontana M, Gilbertson J, Castelletti S, White S, Scully P . Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. Circ Cardiovasc Imaging. 2016; 9(8). DOI: 10.1161/CIRCIMAGING.116.005066. View

4.
Dahl J, Magne J, Pellikka P, Donal E, Marwick T . Assessment of Subclinical Left Ventricular Dysfunction in Aortic Stenosis. JACC Cardiovasc Imaging. 2019; 12(1):163-171. DOI: 10.1016/j.jcmg.2018.08.040. View

5.
Rapezzi C, Quarta C, Riva L, Longhi S, Gallelli I, Lorenzini M . Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol. 2010; 7(7):398-408. DOI: 10.1038/nrcardio.2010.67. View